Research map: The Pitfalls of Categorizing Donor Age: Arbitrary Cutoffs Fail to Predict Survival in Haploidentical HCT

Back to the article

Papers in this map

  1. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation · Francisco M. Marty · 2017 · 1248 citations · Cited by this paper
  2. Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management · 2026 · Related
  3. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease · Robert Zeiser · 2020 · 913 citations · Cited by this paper
  4. Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma · 2026 · Related
  5. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study · Corey S. Cutler · 2021 · 353 citations · Cited by this paper
  6. Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia · 2026 · Related
  7. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 · Mark J. Levis · 2024 · 222 citations · Cited by this paper
  8. Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”? · 2026 · Related
  9. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide · Amy Elizabeth Dezern · 2021 · 109 citations · Cited by this paper
  10. ICC / WHO ‐Defined and NGS ‐Annotated Idiopathic Hypereosinophilia ( iHES / iHE ): Mutations, Clinical and Treatment Details, and Predictors of Survival · 2026 · Related
  11. Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide · Shannon R. McCurdy · 2018 · 100 citations · Cited by this paper
  12. Promoter TERT ‐ Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders · 2026 · Related
  13. Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome · Stefan Octavian Ciurea · 2017 · 99 citations · Cited by this paper
  14. Mosaic Chromosomal Alterations Identify Ultra‐High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy · 2026 · Related
  15. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation · Jonathan Canaani · 2017 · 90 citations · Cited by this paper
  16. A New Fetal Hemoglobin‐Related Phenotype in Sickle Cell Anemia · 2026 · Related
  17. Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy · Jacopo Mariotti · 2020 · 66 citations · Cited by this paper
  18. p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases · 2026 · Related
  19. Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide · Rohtesh S. Mehta · 2022 · 45 citations · Cited by this paper
  20. Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma · 2026 · Related
  21. Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT · Jaime Sanz · 2024 · 34 citations · Cited by this paper
  22. Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age · Rima M. Saliba · 2023 · 16 citations · Cited by this paper
  23. Long‐term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo‐controlled, phase 3 QUAZAR AML ‐001 trial · Andrew H. Wei · 2023 · 13 citations · Cited by this paper
  24. Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis · Yosra M. Aljawai · 2025 · 10 citations · Cited by this paper
  25. Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation · Rohtesh S. Mehta · 2025 · 6 citations · Cited by this paper

Source: OpenAlex (CC0)